Nanalysis Scientific (CVE:NSCI) Hits New 1-Year Low – Here’s Why

Nanalysis Scientific Corp. (CVE:NSCI) shares reached a new 52-week low on Tuesday . The company traded as low as C$0.11 and last traded at C$0.12, with a volume of 43618 shares changing hands. The stock had previously closed at C$0.13.

Nanalysis Scientific Stock Performance

The stock’s 50-day moving average is C$0.15 and its 200-day moving average is C$0.17. The firm has a market capitalization of C$13.78 million, a price-to-earnings ratio of -1.20 and a beta of -0.75. The company has a current ratio of 1.42, a quick ratio of 1.11 and a debt-to-equity ratio of 71.72.

Nanalysis Scientific Company Profile

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.